Company profilePharmaceutical#96 of 1,318 in Pakistan✓ No DRAP alerts

INDUS PHARMA (PVT) LTD.

Pharmaceutical company · 170 brands · 180 molecules

Ranked #23 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

170 registered products 50 pharmaceutical brands 180 distinct molecules 0 DRAP alerts

Company overview

170
registered products
50
pharmaceutical brands
180
distinct molecules
12
therapeutic classes
0
DRAP alerts

INDUS PHARMA (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 170 product registrations across 180 distinct molecules. It is the 96th largest registrant in Pakistan by product count, and ranks 23rd of 213 in Other Beta-Lactam, Cephalosporins & Penems. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by INDUS

104 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

60
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252
202658

Top molecules by brand count

Ceftriaxone6 brands
Diclofenac4 brands
Thiamine4 brands
Pyridoxine4 brands
Telmisartan4 brands
Cefixime4 brands
Omeprazole4 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 9Anti-Infectives · 8Quinolone Antibacterials · 6Antiinflammatory And Antirheumatic Products · 5Blood Glucose Lowering Drugs, Excluding Insulin · 5Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 5Angiotensin-Ii Antagonists, Combinations · 5Gastro · 4Opioids · 4Macrolides, Lincosamides And Streptogramins · 4Pain Management · 3Antiepileptics · 3

Conditions treated

General Infections · 8Ors · 2Pain Killers · 2Asthma/Allergy · 1Heart Failure · 1Bleeding Disorder · 1Anxiety/Depression/Insomnia · 1Vomiting/Emesis · 1Ulcer/Reflux/Flatulence/Acidity · 1Contraceptives · 1Anaesthesia · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official97 products · Rs 64.74 – Rs 7,587.02
DVAGO39 products · Rs 24.5 – Rs 3,464
Servaid31 products · Rs 93.2 – Rs 1,937
Median across source: Rs 285

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 235 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
SEARLE PAKISTAN (PVT.) LTD. holds 199 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
BIO LABS (PVT) LTD. holds 113 molecules not in this portfolio
000 I.UAprepitantAremetherArtemetherArtesunateAscorbic Acid

Get the full profile for INDUS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.